Robert P. Tonge

486 citations
9 papers · 405 indexed · h-index 7
Topics
Drug-Induced Hepatotoxicity and Protection (4 papers)Liver physiology and pathology (3 papers)Gene expression and cancer classification (3 papers)

In The Last Decade

Robert P. Tonge

9 papers receiving 382 citations

Peers

Robert P. Tonge
Comparison fields: 5 of 78
  • Pharmacology 178
  • Molecular Biology 159
  • Spectroscopy 89
  • Oncology 76
  • Hepatology 75
Replace David F. Gebhard with:
David F. Gebhard United States
Charles E. Ruegg United States
Stella O. Sieber United States
Frederic Moulin United States
Tadahaya Mizuno Japan
Simone H. Stahl United Kingdom
Michio Hara Japan
Erio Barale-Thomas United States
Daniel Y. Hung Australia
Tarundeep Kakkar United States
Robert P. Tonge relative to David F. Gebhard United States David F. Gebhard's profile →
Citations per field
00.5×4.7×
David F. Gebhard · 1×
Citations per year

Countries citing papers authored by Robert P. Tonge

Since Specialization
Citations

This map shows the geographic impact of Robert P. Tonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Tonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Tonge more than expected).

Fields of papers citing papers by Robert P. Tonge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Tonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Tonge. The network helps show where Robert P. Tonge may publish in the future.

Co-authorship network of co-authors of Robert P. Tonge

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Tonge. A scholar is included among the top collaborators of Robert P. Tonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Tonge. Robert P. Tonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 82
2 20
3 43
4 39
5 2
6 51
7 85
8 1
9 82

About Robert P. Tonge

Robert P. Tonge is a scholar working on Biophysics, Pharmacology and Hepatology, having authored 9 papers that have together received 405 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (4 papers), Liver physiology and pathology (3 papers) and Gene expression and cancer classification (3 papers). The work is most often cited by research in Pharmacology (178 citations), Hepatology (75 citations) and Biophysics (36 citations). Robert P. Tonge has collaborated with scholars based in United Kingdom, United States and Austria. Frequent co-authors include Mike Rogers, Sam A. Bruschi, Jim Graham, Nelson Fausto, Robert H. Pierce, Sidney D. Nelson, Edward J. Kelly, D W Nebert, David L. Eaton and Sidney D. Nelson. Their work appears in journals such as Clinical Cancer Research, Biochemical Pharmacology and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026